Patent US5047237A successfully refreshed from Google Patents.
US5047237A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Attenuated pseudorabies virus having a deletion of at least a portion of a gene encoding an antigenic, nonessential protein, vaccine containing same and methods of identifying animals vaccinated with the vaccine
Assignee: Prutech Research and Development Partnership
•
Filing: 1988-05-11
•
Granted: 1991-09-10
•
Expires: 2008-05-11
Abstract
Abstract Attenuated pseudorabies viruses are provided which comprise DNA including a sequence essential for replication of the attenuated pseudorabies virus, at least a portion of which is present in a sequence essential for replication of a naturally-occurring pseudorabies virus. The DNA encodes mRNAs which, in an animal infected with the attenuated pseudorabies virus, are translated into antigenic pseudorabies virus gene products which invoke in the infected animal an immunological response distinguishable from an immunological response invoked in an animal infected with a naturally-occurring pseudorabies virus. Also provided are vaccines which comprise the attenuated pseudorabies virus of the present invention and methods of immunizing animals against pesudorabies virus disease. The invention further provides a method for distinguishing an animal vaccinated with a vaccine of the present invention from an animal infected with a naturally-occuring pseudorabies virus.
Inventors
- 👤 Mark D. Cochran
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-07 08:50
CPC Classifications
C; C12; C12Q; C12Q1/00; C12Q1/70; C12Q1/701; C12Q1/705; A; A61; A61K; A61K39/00; A61K39/12; A61K39/245; A61K39/265; C07; C07K; C07K14/00; C07K14/005; C12N; C12N15/00; C12N15/09; C12N15/63; C12N15/79; C12N15/85; C12N15/86; A61K2039/51; A61K2039/525; A61K2039/5254; A61K2039/55; A61K2039/552; C07K2319/00; C07K2319/01; C07K2319/02; C12N2710/00; C12N2710/00011; C12N2710/16011; C12N2710/16711; C12N2710/16722; C12N2710/16734; C12N2710/16741; C12N2710/16743; C12N2750/00; C12N2750/00011; C12N2750/14011; C12N2750/14311; C12N2750/14322
Claims Analysis
Total Claims: 8
Claim 1
Independent Claim
24 words
A vaccine which comprises an effective immunizing amount of an attenuated pseudorabies virus designated S-PRV-013 (ATCC Accession No. VR 2120) and a suitable carrier.
Claim 2
Dependent Claim
24 words
A vaccine which comprises an effective immunizing amount of an attenuated pseudorabies virus designated S-PRV-013 (ATCC Accession No. VR 2120) and a suitable carrier.
Claim 3
Dependent Claim
24 words
A method of immunizing an animal against pseudorabies virus which comprises administering to the animal an immunizing dose of the vaccine of claim 1.
Claim 4
Dependent Claim
11 words
The method of claim 2, wherein the animal is a swine.
Claim 5
Dependent Claim
120 words
A method for distinguishing an animal vaccinated with the vaccine of claim 1 from an animal infected with a naturally-occurring pseudorabies virus which comprises analyzing a sample of a body fluid from the animal for the presence of glycoprotein X and at least one other antigen normally expressed in an animal infected by a naturally-occurring pseudorabies virus, identifying antigens which are present in the body fluid and determining whether glycoprotein X is present in the body fluid, the presence of antigens which are normally expressed in an animal by a naturally-occurring pseudorabies virus and the absence of glycoprotein X in the body fluid being indicative of an animal vaccinated with the vaccine and not infected with a naturally-occurring pseudorabies virus.
Claim 6
Dependent Claim
33 words
The method of claim 4, wherein the presence of antigens and glycoprotein X in the body fluid is determined by detecting in the body fluid antibodies specific for the antigens and glycoprotein X.
Claim 7
Dependent Claim
114 words
A method for distinguishing an animal vaccinated with the vaccine of claim 1 from an animal infected with a naturally-occurring pseudorabies virus which comprises analyzing a sample of a body fluid from the animal for the presence of glycoprotein X and at least one other antigen expressed in an animal vaccinated with S-PRV-013, identifying antigens which are present in the body fluid and determining whether glycoprotein X is present in the body fluid, the presence of an antigen which is expressed in an animal vaccinated with S-PRV-013 and the absence of glycoprotein X in the body fluid being indicative of an animal vaccinated with the vaccine and not infected with a naturally-occurring pseudorabies virus.
Claim 8
Dependent Claim
17 words
A method of claim 6 wherein the antigen expressed in an animal vaccinated with S-PRV-013 is β-galactosidase.
References Cited (Backward Citations)
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1994-09-09 | 1995-03-11 | 1995-09-10 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1998-09-09 | 1999-03-11 | 1999-09-10 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2002-09-09 | 2003-03-11 | 2003-09-10 | $7700.00 | Window Closed / Lapsed |